Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Prestige Brand Holdings (PBH)

Prestige Brand Holdings (PBH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,483,301
  • Shares Outstanding, K 47,319
  • Annual Sales, $ 1,138 M
  • Annual Income, $ 214,610 K
  • EBIT $ 355 M
  • EBITDA $ 387 M
  • 60-Month Beta 0.47
  • Price/Sales 2.34
  • Price/Cash Flow 11.06
  • Price/Book 1.49

Options Overview Details

View History
  • Implied Volatility 35.03% (+2.03%)
  • Historical Volatility 34.79%
  • IV Percentile 54%
  • IV Rank 42.92%
  • IV High 71.88% on 12/05/25
  • IV Low 7.31% on 09/05/25
  • Expected Move (DTE 12) 0.47 (0.89%)
  • Put/Call Vol Ratio 3.00
  • Today's Volume 12
  • Volume Avg (30-Day) 23
  • Put/Call OI Ratio 1.17
  • Today's Open Interest 665
  • Open Int (30-Day) 633
  • Expected Range 52.01 to 52.95

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $1.44
  • Number of Estimates 4
  • High Estimate $1.59
  • Low Estimate $1.39
  • Prior Year $1.32
  • Growth Rate Est. (year over year) +9.09%

Price Performance

See More
Period Period Low Period High Performance
1-Month
51.28 +2.34%
on 04/02/26
69.51 -24.50%
on 03/04/26
-16.05 (-23.42%)
since 03/02/26
3-Month
51.28 +2.34%
on 04/02/26
71.07 -26.16%
on 02/24/26
-8.74 (-14.28%)
since 01/02/26
52-Week
51.28 +2.34%
on 04/02/26
89.37 -41.28%
on 05/16/25
-33.55 (-39.00%)
since 04/02/25

Most Recent Stories

More News
Prestige Consumer Healthcare Announces Agreement to Acquire Breathe Right®, the Leader in Nasal Strips

Entered agreement to acquire a portfolio of brands with revenue of $200 million and EBITDA of $95 million Breathe Right is an iconic and category‑leading brand with strong margins and cash flow generation...

PBH : 52.48 (-9.02%)
Prestige Consumer Healthcare: Fiscal Q3 Earnings Snapshot

Prestige Consumer Healthcare: Fiscal Q3 Earnings Snapshot

PBH : 52.48 (-9.02%)
Prestige Consumer Healthcare Inc. Reports Third Quarter and Year-to-Date Fiscal 2026 Results

Revenue of $283.4 million in Q3, ahead of outlook Diluted EPS of $0.97 in Q3 and Adjusted Diluted EPS of $1.14, versus prior year Q3 Diluted EPS of $1.22 Repurchased approximately 0.8 million shares...

PBH : 52.48 (-9.02%)
Prestige Consumer Healthcare Announces Fiscal 2026 Third Quarter Earnings Results Date and Participation in the ICR Conference

TARRYTOWN, N.Y., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (the “Company” or “Prestige”) (NYSE: PBH) today announced it will issue its fiscal 2026 third quarter earnings...

PBH : 52.48 (-9.02%)
Prestige Consumer Healthcare: Fiscal Q2 Earnings Snapshot

Prestige Consumer Healthcare: Fiscal Q2 Earnings Snapshot

PBH : 52.48 (-9.02%)
Prestige Consumer Healthcare Inc. Reports Second Quarter and First Half Fiscal 2026 Results

Revenue of $274.1 million in Q2, ahead of outlook Diluted EPS of $0.86 in Q2 and Adjusted Diluted EPS of $1.07, versus prior year Q2 Diluted EPS of $1.09 Repurchased approximately 1.1 million shares...

PBH : 52.48 (-9.02%)
Prestige Consumer Healthcare to Release Fiscal 2026 Second Quarter Earnings Results

TARRYTOWN, N.Y., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2026 second quarter and first half earnings release on Thursday,...

PBH : 52.48 (-9.02%)
Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference

TARRYTOWN, N.Y., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the Barclays Global Consumer Staples Conference on Thursday, September...

PBH : 52.48 (-9.02%)
Prestige Consumer Healthcare: Fiscal Q1 Earnings Snapshot

Prestige Consumer Healthcare: Fiscal Q1 Earnings Snapshot

PBH : 52.48 (-9.02%)
Prestige Consumer Healthcare Inc. Reports Fiscal 2026 First Quarter Results

Revenue of $249.5 million in Q1; decline driven by limited eye care supply Diluted EPS of $0.95 in Q1, up approximately 6% versus prior year Adjusted Diluted EPS of $0.90 Announces agreement to acquire...

PBH : 52.48 (-9.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 30%. The market has entered oversold territory.

See More Share

Business Summary

Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products,...

See More

Key Turning Points

3rd Resistance Point 62.18
2nd Resistance Point 59.76
1st Resistance Point 56.12
Last Price 52.48
1st Support Level 50.06
2nd Support Level 47.64
3rd Support Level 44.00

See More

52-Week High 89.37
Fibonacci 61.8% 74.82
Fibonacci 50% 70.33
Fibonacci 38.2% 65.83
Last Price 52.48
52-Week Low 51.28

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.